Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A consensus statement
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A consensus statement
Authors
Keywords
-
Journal
Multiple Sclerosis Journal
Volume -, Issue -, Pages 135245852211342
Publisher
SAGE Publications
Online
2022-12-17
DOI
10.1177/13524585221134217
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Kappa Free Light Chains in the Context of Blood Contamination, and Other IgA- and IgM-Related Cerebrospinal Fluid Disease Pattern
- (2021) Malte Johannes Hannich et al. Cells
- Kappa free light chain index as a diagnostic biomarker in multiple sclerosis: A real‐world investigation
- (2021) Igal Rosenstein et al. JOURNAL OF NEUROCHEMISTRY
- Cerebrospinal Fluid Findings in 541 Patients With Clinically Isolated Syndrome and Multiple Sclerosis: A Monocentric Study
- (2021) Klaus Berek et al. Frontiers in Immunology
- Evaluation of Kappa Index as a Tool in the Diagnosis of Multiple Sclerosis: Implementation in Routine Screening Procedure
- (2021) Carmen Teresa Sanz Diaz et al. Frontiers in Neurology
- Kappa-Free Light Chains in CSF Predict Early Multiple Sclerosis Disease Activity
- (2021) Klaus Berek et al. Neurology-Neuroimmunology & Neuroinflammation
- CSF Kappa Free Light Chains: Cutoff Validation for Diagnosing Multiple Sclerosis
- (2021) Ruba S. Saadeh et al. MAYO CLINIC PROCEEDINGS
- The contribute of cerebrospinal fluid free light-chain assay in the diagnosis of multiple sclerosis and other neurological diseases in an Italian multicenter study
- (2021) Gaetano Bernardi et al. Multiple Sclerosis Journal
- The Increasing Role of Kappa Free Light Chains in the Diagnosis of Multiple Sclerosis
- (2021) Franz Felix Konen et al. Cells
- Bing-Neel Syndrome: Update on the Diagnosis and Treatment
- (2021) Abdelrahman Nanah et al. Clinical Lymphoma Myeloma & Leukemia
- The Impact of Immunomodulatory Treatment on Kappa Free Light Chains as Biomarker in Neuroinflammation
- (2020) Franz Felix Konen et al. Cells
- Kappa Free Light Chains and IgG Combined in a Novel Algorithm for the Detection of Multiple Sclerosis
- (2020) Monika Gudowska-Sawczuk et al. Brain Sciences
- Diagnostic accuracy of intrathecal kappa free light chains compared with OCBs in MS
- (2020) Frida Duell et al. Neurology-Neuroimmunology & Neuroinflammation
- Free light chain kappa and the polyspecific immune response in MS and CIS – Application of the hyperbolic reference range for most reliable data interpretation
- (2020) Marie Süße et al. JOURNAL OF NEUROIMMUNOLOGY
- Prognostic value of kappa free light chains determination in first-ever multiple sclerosis relapse
- (2020) Manuel Salavisa et al. JOURNAL OF NEUROIMMUNOLOGY
- Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients
- (2020) Sven Jarius et al. Journal of Neuroinflammation
- Impact of intrathecal IgG synthesis on neurological disability in patients with multiple sclerosis
- (2020) Tetsuya Akaishi et al. Multiple Sclerosis and Related Disorders
- IgG Index Revisited: Diagnostic Utility and Prognostic Value in Multiple Sclerosis
- (2020) Yang Zheng et al. Frontiers in Immunology
- Free light chains kappa can differentiate between myelitis and noninflammatory myelopathy
- (2020) Marie Süße et al. Neurology-Neuroimmunology & Neuroinflammation
- Kappa Index versus CSF Oligoclonal Bands in Predicting Multiple Sclerosis and Infectious/Inflammatory CNS Disorders
- (2020) Diana Ferraro et al. Diagnostics
- Intrathecal kappa free light chains as markers for multiple sclerosis
- (2020) D. Vecchio et al. Scientific Reports
- Free light chains in the cerebrospinal fluid. Comparison of different methods to determine intrathecal synthesis
- (2019) Harald Hegen et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study
- (2019) CE Leurs et al. Multiple Sclerosis Journal
- Kappa free light chains could predict early disease course in multiple sclerosis
- (2019) D. Vecchio et al. Multiple Sclerosis and Related Disorders
- K Index is a Reliable Marker of Intrathecal Synthesis, and an Alternative to IgG Index in Multiple Sclerosis Diagnostic Work-Up
- (2019) Ilaria Crespi et al. Journal of Clinical Medicine
- The clinical significance of single or double bands in cerebrospinal fluid isoelectric focusing. A retrospective study and systematic review
- (2019) Harald Hegen et al. PLoS One
- Free light chains in cerebrospinal fluid of multiple sclerosis patients negative for IgG oligoclonal bands
- (2019) Sara Altinier et al. CLINICA CHIMICA ACTA
- Diagnostic relevance of free light chains in cerebrospinal fluid – The hyperbolic reference range for reliable data interpretation in quotient diagrams
- (2019) Hansotto Reiber et al. CLINICA CHIMICA ACTA
- Reiber’s Diagram for Kappa Free Light Chains: The New Standard for Assessing Intrathecal Synthesis?
- (2019) Philipp Schwenkenbecher et al. Diagnostics
- Cerebrospinal fluid kappa and lambda free light chains in oligoclonal band‐negative patients with suspected multiple sclerosis
- (2019) D. Ferraro et al. EUROPEAN JOURNAL OF NEUROLOGY
- Cerebrospinal fluid free light chains compared to oligoclonal bands as biomarkers in multiple sclerosis
- (2019) Lorenzo Gaetani et al. JOURNAL OF NEUROIMMUNOLOGY
- Kappa free light chains index in the differential diagnosis of Multiple Sclerosis from Neuromyelitis optica spectrum disorders and other immune-mediated central nervous system disorders
- (2019) P. Cavalla et al. JOURNAL OF NEUROIMMUNOLOGY
- Clinical Use of κ Free Light Chains Index as a Screening Test for Multiple Sclerosis
- (2019) Luisa Agnello et al. Labmedicine
- Free Kappa light chains in neuroinflammatory disorders: Complement rather than substitute?
- (2018) J.-L. Bayart et al. ACTA NEUROLOGICA SCANDINAVICA
- The value of oligoclonal bands in the multiple sclerosis diagnostic criteria
- (2018) Georgina Arrambide et al. BRAIN
- Reference intervals and diagnostic ranges for serum free κ and free λ immunoglobulin light chains vary by instrument platform: Implications for classification of patient results in a multi-center study
- (2018) Steven W. Cotten et al. CLINICAL BIOCHEMISTRY
- Application of κ free light chains in cerebrospinal fluid as a biomarker in multiple sclerosis diagnosis: development of a diagnosis algorithm
- (2018) Estefania Valencia-Vera et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- CSF free light chain identification of demyelinating disease: comparison with oligoclonal banding and other CSF indexes
- (2018) Kari M. Gurtner et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Cerebrospinal fluid free light chains as diagnostic biomarker in neuroborreliosis
- (2018) Harald Hegen et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Kappa free light chains in cerebrospinal fluid to identify patients with oligoclonal bands
- (2018) M. Süße et al. EUROPEAN JOURNAL OF NEUROLOGY
- Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
- (2018) Alan J Thompson et al. LANCET NEUROLOGY
- Cerebrospinal fluid free kappa light chains and kappa index perform equal to oligoclonal bands in the diagnosis of multiple sclerosis
- (2018) Mikael Christiansen et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Relevance of KFLC quantification to differentiate clinically isolated syndrome from multiple sclerosis at clinical onset
- (2018) Marina Vasilj et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Intrathecal K free light chain synthesis in multiple sclerosis at clinical onset associates with local IgG production and improves the diagnostic value of cerebrospinal fluid examination
- (2018) M. Puthenparampil et al. Multiple Sclerosis and Related Disorders
- The Persisting Significance of Oligoclonal Bands in the Dawning Era of Kappa Free Light Chains for the Diagnosis of Multiple Sclerosis
- (2018) Philipp Schwenkenbecher et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Validation of CSF free light chain in diagnosis and prognosis of multiple sclerosis and clinically isolated syndrome: prospective cohort study in Buenos Aires
- (2018) María Soledad Sáez et al. JOURNAL OF NEUROLOGY
- Intrathecal immunoglobulin synthesis: The potential value of an adjunct test
- (2018) Andreja Emersic et al. CLINICA CHIMICA ACTA
- KFLC Index utility in multiple sclerosis diagnosis: Further confirmation
- (2017) M. Pieri et al. JOURNAL OF NEUROIMMUNOLOGY
- Cerebrospinal fluid humoral immunity in the differential diagnosis of multiple sclerosis
- (2017) Evanthia Bernitsas et al. PLoS One
- Quantitation of intrathecal immunoglobulin synthesis - a new empirical formula
- (2016) M. Auer et al. EUROPEAN JOURNAL OF NEUROLOGY
- Clinical significance of the number of oligoclonal bands in patients with clinically isolated syndromes
- (2015) Gloria Dalla Costa et al. JOURNAL OF NEUROIMMUNOLOGY
- Validation of kappa free light chains as a diagnostic biomarker in multiple sclerosis and clinically isolated syndrome: A multicenter study
- (2015) Stefan Presslauer et al. Multiple Sclerosis Journal
- Validation of kappa free light chains as a diagnostic biomarker in multiple sclerosis and clinically isolated syndrome: A multicenter study
- (2015) Stefan Presslauer et al. Multiple Sclerosis Journal
- High sensitivity and specificity of elevated cerebrospinal fluid kappa free light chains in suspected multiple sclerosis
- (2014) G. Hassan-Smith et al. JOURNAL OF NEUROIMMUNOLOGY
- Kappa Free Light Chains: Diagnostic and Prognostic Relevance in MS and CIS
- (2014) Stefan Presslauer et al. PLoS One
- Biological variation of free light chains in serum
- (2013) Charlotte Toftmann Hansen et al. CLINICA CHIMICA ACTA
- Determination of kFLC and K Index in cerebrospinal fluid: A valid alternative to assessintrathecal immunoglobulin synthesis
- (2013) Fabio Duranti et al. JOURNAL OF NEUROIMMUNOLOGY
- Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude
- (2013) R. Dobson et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis
- (2013) Charlotte Teunissen et al. Multiple Sclerosis Journal
- Biological variation of free light chains in serum
- (2012) Federica Braga et al. CLINICA CHIMICA ACTA
- Evaluation of the N Latex FLC free light chain assay on the Siemens BN analyser: precision, agreement, linearity and variation between reagent lots
- (2012) C. J. Pretorius et al. ANNALS OF CLINICAL BIOCHEMISTRY
- Free immunoglobulin light chain: Its biology and implications in diseases
- (2011) Takanari Nakano et al. CLINICA CHIMICA ACTA
- N Latex FLC – new monoclonal high-performance assays for the determination of free light chain kappa and lambda
- (2011) Henk te Velthuis et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Pathognomonic cerebrospinal fluid findings in Bing–Neel syndrome
- (2011) Henrik Zetterberg JOURNAL OF NEURO-ONCOLOGY
- Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: Results from 211 lumbar punctures
- (2011) S. Jarius et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking
- (2009) C. E. Teunissen et al. NEUROLOGY
- Elevated levels of kappa free light chains in CSF support the diagnosis of multiple sclerosis
- (2008) S. Presslauer et al. JOURNAL OF NEUROLOGY
- International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders
- (2008) A Dispenzieri et al. LEUKEMIA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now